ATM and cancer: Despite the fact that no ATM inhibitors are yet in clinical development and no ATR inhibitors have reached approval, the in vitro studies carried out to date clearly show that pharmacological inhibition of ATM and ATR has great potential in cancer therapy in combination with radiotherapy or certain chemotherapeutic drugs including trabectedin and lurbinectedin.